2024-07-09
Founded in January 1985, Livzon Pharmaceutical Group Co., Ltd. is a comprehensive pharmaceutical group company integrating pharmaceutical product research and development, production and sales, and is an A+H-share listed company. In 2023, the company's operating income was 12.43 billion yuan, net profit was 1.954 billion yuan, and R&D investment was 1.235 billion yuan, accounting for 9.94% of operating income.
The company regards R&D innovation as the cornerstone of sustainable development, and continues to pay attention to new molecules and cutting-edge technologies in the field of global new drug research and development. Based on clinical value and differentiation, it has forward-looking layouts of innovative drugs and high-barrier complex preparations, focusing on the fields of digestive tract, assisted reproduction, mental health, tumor immunity, etc., forming a complete product cluster and a differentiated product pipeline covering the entire R&D cycle.
Send your inquiry directly to us